483 Catalent Indiana Sep 2020

483 Catalent Indiana Sep 2020

Michael Shanks FDA$119.00 - Available Now

FDA investigators audited the Catalent Indiana - Bloomington, IN, United States facility and issued inspectional observations (via FDA 483) on 02 Sep 2020.

Product details

  • Category: Human Drugs
  • Inspection end: 02 Sep 2020
  • Location: Bloomington, United States
  • FEI: 3005949964
Add To Cart